Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001415889-25-004199·Decheng Capital Global Life Sciences Fund IV, L.P.
Schedule 13G ownership disclosure
Upstream Bio Inc
Common Stock, par value $0.001 per share · CUSIP: 91678A107
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Decheng Capital Global Life Sciences Fund IV, L.P.
Shares: 3,085,293.00 · Class: 5.8%
- Decheng Capital Management IV (Cayman), LLC
Shares: 3,085,293.00 · Class: 5.8%
- Decheng Capital Global Healthcare Fund (Master), LP
Shares: 200,000.00 · Class: 0.4%
- Decheng Capital Global Healthcare GP, LLC
Shares: 200,000.00 · Class: 0.4%
- Xiangmin Cui
Shares: 3,285,293.00 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-004199
- Form type
- SCHEDULE 13G
- Filer
- Decheng Capital Global Life Sciences Fund IV, L.P.
- CIK
- CIK 1834150
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership